FDA•MODERATE
Cetrorelix Acetate for Injection Kit 0.25 mg
Meitheal Pharmaceuticals recalls Cetrorelix Acetate injection kits (NDC 71288-558-90) due to missing or duplicated needles.
Filters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•MODERATEThiamine HCl InjectionFagron Sterile Services is recalling Thiamine HCl 500 mg injection due to a lack of assurance of sterility.
5 products
FDA•MODERATEDexamethasone Sodium Phosphate Injection, USP 100 mg/10 mLSomerset Therapeutics is recalling Dexamethasone Sodium Phosphate Injection (NDC 70069-025-10/01) due to out-of-specification impurities at expiry.
FDA•LOWPitavastatin Tablets, 2 mgNorthstar Rx LLC is recalling Pitavastatin Tablets, 2 mg (NDC 72603-479-01) due to a foreign 1 mg tablet found in bottles.
FDA•MODERATEPro Numb Tattoo Numbing SprayPro Numb is recalling 5% Lidocaine Tattoo Numbing Spray due to cGMP manufacturing deviations.
2 products
FDA•MODERATEMetoprolol Succinate Extended-Release TabletsTeva is recalling Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications.
4 products
FDA•MODERATEDiclofenac Sodium Topical Gel 3%Taro Pharmaceuticals is recalling Diclofenac Sodium Topical Gel 3% (100 g) due to viscosity specification failure.
FDA•MODERATEAsteria Health Testosterone Sterile PelletsAsteria Health is recalling 100 mg Testosterone sterile pellets due to the potential presence of metal particulate matter.
25 products
FDA•MODERATETrazodone Hydrochloride 50 mg TabletsGranules Pharmaceuticals is recalling Trazodone Hydrochloride 50 mg tablets (NDC 70010-231-01) due to foreign tablets or capsules in bottles.
FDA•MODERATESodium Iodide (I-131) Therapeutic Oral SolutionRadnostix is recalling Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter.
FDA•MODERATEBisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mgUnichem Pharmaceuticals recalls Bisoprolol/Hydrochlorothiazide 2.5/6.25 mg tablets (NDC 29300-187-01) due to N-Nitroso Bisoprolol impurity specification failure.
FDA•LOWDoxazosin Tablets, USP 4 mgUnichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
FDA•MODERATEMed Nap BZK Antiseptic TowelettesAcme United is recalling Med Nap BZK Antiseptic Towelettes (NDC 0924-0246-01) due to CGMP deviations.
22 products
FDA•CRITICALUDENYCA Pegfilgrastim-cbqv InjectionUDENYCA pegfilgrastim-cbqv prefilled syringes (Lot 2199821) recalled due to improper storage temperature.
FDA•MODERATEThyroid, USPSpecialty Process Labs is recalling Thyroid, USP (NDC 81305-100-02) due to subpotency.
FDA•MODERATEMethylprednisolone Tablets USP Dosepak 4 mgGreenstone is recalling methylprednisolone 4 mg tablets (NDC 59762-4440-2) due to incorrect blister foil orientation causing incorrect dosing information.
FDA•MODERATEOxycodone Hydrochloride Tablets, USP 5 mgAmerican Health Packaging is recalling Oxycodone Hydrochloride 5 mg tablets due to defective blister card seals that allow tablets to fall out.
FDA•MODERATEIsotretinoin 40 mg CapsulesTeva is recalling Isotretinoin 40 mg capsules due to superpotency and subpotency concerns that may affect treatment efficacy or safety.
2 products
FDA•MODERATEFurosemide Tablets USP 40 mgRising Pharmaceuticals is recalling Furosemide Tablets 40 mg (NDC 64980-563-10) due to foreign substance contamination.
FDA•MODERATEAQ 120 GFEW Aquarion Preserved CartridgesEncon Safety Products is recalling AQ 120 GFEW Aquarion Preserved Cartridges due to cGMP manufacturing deviations.
FDA•MODERATELanreotide Injection 120 mg/0.5 mLCipla is recalling Lanreotide Injection 120 mg/0.5 mL (NDC 69097-870-67) due to particulate matter contamination.